Clinical trials
Nontuberculous Mycobacterial Lung Disease clinical trials
Below are recruiting nontuberculous mycobacterial lung disease clinical trials, each written for real people, not researchers. We’re tracking 9 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05678166Recruiting
Testing a blood marker to predict worsening lung mycobacterial disease
This study checks whether a blood test called soluble programmed death-1 can help predict how nodular-bronchiectatic nontuberculous mycobacterial (NTM) lung disease will progress. Results may help doctors monitor patients more accurately and decide when to treat or follow more closely.
TaipeiAges 20 years+ - NCT04921943RecruitingPhase 4
Hypertonic saline to treat MAC lung infection
This trial tests whether inhaled hypertonic saline can improve symptoms and lung health in people with a specific lung infection called MAC. It targets adults with confirmed MAC infection and bronchiectasis who are not already on certain MAC medications.
New York, New YorkAges 18 years+ - NCT05192057RecruitingPhase 4
Inhaling salty steam for lung MAC infection
This trial studies whether inhaling hypertonic (very salty) saline helps treat nodular-bronchiectatic lung disease caused by Mycobacterium avium complex (MAC). It may help reduce ongoing infection and symptoms if you have the right type of MAC lung pattern and have not recently started the usual MAC treatments.
NijmegenAges 18 years+ - NCT06266442Recruiting
DNA study of M. avium in lung infection
This study looks at the DNA of the bacteria causing your lung infection (Mycobacterium avium) to understand treatment better. It involves analyzing stored samples and may include patients who have been treated before.
Toronto, OntarioAges 18 years+ - NCT07076238Recruiting
Phage therapy for hard-to-treat bacterial infections
This study looks at how well phage therapy works for people with stubborn bacterial infections, like NTM. If your doctor is already considering phage therapy as part of your care, this trial may help track your response.
New York, New YorkAges 18 years+ - NCT07647575Recruiting
Salt Water Inhalation for Nontuberculous Mycobacterial Lung Disease
This trial tests whether breathing salt water vapor through a home nebulizer machine helps people with a specific type of lung infection (nontuberculous mycobacteria). The goal is to see if this simple treatment can improve breathing and reduce symptoms.
TaipeiAges 18 years+ - NCT06262282Enrolling by invitation
Phage therapy for stubborn NTM infection in cystic fibrosis
This trial tests whether a special virus therapy (phage) can help clear stubborn NTM lung infections in people with cystic fibrosis who have been on antibiotics for over a year without success. Participants will continue their antibiotics while receiving the phages.
Birmingham, AlabamaAges 6 years+ - NCT06585020RecruitingPhase 2
Inhaled antibiotic for Mycobacterium xenopi lung infection
This trial tests an inhaled antibiotic (amikacin liposome) for people with a lung infection caused by a germ called Mycobacterium xenopi. The goal is to see if this treatment can help fight the infection with fewer side effects.
AmiensAges 18 years+ - NCT00943514Recruiting
Study of bronchiectasis and why infections keep coming back
This study follows children (age 5+) and adults with bronchiectasis or ongoing/repeated lung infections to learn what makes infections more likely. It mainly looks at non–cystic fibrosis causes, but may include some related conditions to compare differences.
Bethesda, MarylandAges 5–100
Hear when a new Nontuberculous Mycobacterial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Nontuberculous Mycobacterial Lung Disease trials by city
Studies with a site in or near these metro areas.
Nontuberculous Mycobacterial Lung Disease trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for nontuberculous mycobacterial lung disease?
- Yes. Clin2 currently lists 9 recruiting nontuberculous mycobacterial lung disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a nontuberculous mycobacterial lung disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a nontuberculous mycobacterial lung disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.